Industry
Medical - Devices
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
Loading...
Open
10.98
Mkt cap
329M
Volume
56K
High
11.09
P/E Ratio
-11.26
52-wk high
18.15
Low
10.02
Div yield
N/A
52-wk low
5.45
Portfolio Pulse from
December 18, 2024 | 9:30 pm
Portfolio Pulse from
December 12, 2024 | 9:30 pm
Portfolio Pulse from
November 18, 2024 | 6:15 pm
Portfolio Pulse from
November 18, 2024 | 4:15 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 7:24 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 1:34 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.